Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Inventory (2016 - 2025)

Conmed (CNMD) has disclosed Change in Inventory for 16 consecutive years, with -$8.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 218.23% year-over-year to -$8.5 million, compared with a TTM value of $6.7 million through Dec 2025, down 78.72%, and an annual FY2025 reading of $6.7 million, down 78.72% over the prior year.
  • Change in Inventory was -$8.5 million for Q4 2025 at Conmed, down from $2.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $26.4 million in Q4 2022 and bottomed at -$8.8 million in Q4 2023.
  • Average Change in Inventory over 5 years is $7.0 million, with a median of $5.3 million recorded in 2021.
  • The sharpest move saw Change in Inventory soared 2378.85% in 2024, then plummeted 218.23% in 2025.
  • Year by year, Change in Inventory stood at $3.1 million in 2021, then skyrocketed by 745.47% to $26.4 million in 2022, then crashed by 133.23% to -$8.8 million in 2023, then skyrocketed by 181.92% to $7.2 million in 2024, then tumbled by 218.23% to -$8.5 million in 2025.
  • Business Quant data shows Change in Inventory for CNMD at -$8.5 million in Q4 2025, $2.2 million in Q3 2025, and $5.6 million in Q2 2025.